Literature DB >> 10619512

Evidence-based preoperative evaluation of candidates for thoracotomy.

J J Reilly1.   

Abstract

All patients considered for thoracotomy should have preoperative spirometry. Patients meeting the criteria outlined below should also have quantitative radionuclide perfusion scanning. Patients felt to be at high risk on the basis of predicted postoperative FEV1 should be considered for exercise assessment. If exercise assessment is performed, an MVO2 of < 10-15 mL/kg/min or a predicted postoperative MVO2 < 10 mL/kg/min identifies a patient at very high risk for complications and mortality. Limited available data support the use of preoperative risk indices to identify patients at high risk (See Table 4). Lung volume reduction surgery may provide new approaches in selected patients with significant obstructive lung disease and concomitant lung cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10619512     DOI: 10.1378/chest.116.suppl_3.474s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  1 in total

1.  Joint Guideline on Venous Thromboembolism - 2022.

Authors:  Ana Cristina Lopes Albricker; Cláudia Maria Vilas Freire; Simone Nascimento Dos Santos; Monica Luiza de Alcantara; Mohamed Hassan Saleh; Armando Luis Cantisano; José Aldo Ribeiro Teodoro; Carmen Lucia Lascasas Porto; Salomon Israel do Amaral; Orlando Carlos Gloria Veloso; Ana Cláudia Gomes Pereira Petisco; Fanilda Souto Barros; Márcio Vinícius Lins de Barros; Adriano José de Souza; Marcone Lima Sobreira; Robson Barbosa de Miranda; Domingos de Moraes; Carlos Gustavo Yuji Verrastro; Alexandre Dias Mançano; Ronaldo de Souza Leão Lima; Valdair Francisco Muglia; Cristina Sebastião Matushita; Rafael Willain Lopes; Artur Martins Novaes Coutinho; Diego Bromfman Pianta; Alair Augusto Sarmet Moreira Damas Dos Santos; Bruno de Lima Naves; Marcelo Luiz Campos Vieira; Carlos Eduardo Rochitte
Journal:  Arq Bras Cardiol       Date:  2022-04       Impact factor: 2.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.